[Form 4] LAS VEGAS SANDS CORP Insider Trading Activity

Rhea-AI Filing Summary

Las Vegas Sands (LVS) Chairman & CEO Robert G. Goldstein reported option exercises and open‑market sales. He exercised options at $34.28 and sold the corresponding common shares in two transactions: 40,000 shares on 11/05/2025 at a weighted average price of $62.98 (range $62.58–$63.06), and 360,000 shares on 11/06/2025 at a weighted average price of $63.05 (range $62.73–$63.30).

Following these sales, his direct common stock balance reported for these entries was 0 shares, and he reported 129,005 shares held indirectly by The Robert and Sheryl Goldstein Trust. The options exercised were part of grants with an expiration of 12/02/2031 that vested in three equal annual installments beginning on 12/03/2022. He also reported 2,500,000 vested options remaining and 403,800 unvested RSUs outstanding.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldstein Robert G

(Last) (First) (Middle)

5420 S. DURANGO DRIVE

(Street)

LAS VEGAS NV 89113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LAS VEGAS SANDS CORP [ LVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2025		M		40,000	A	$34.28	40,000	D
Common Stock	11/05/2025		S		40,000	D	$62.98(1)	0	D
Common Stock	11/06/2025		M		360,000	A	$34.28	360,000	D
Common Stock	11/06/2025		S		360,000	D	$63.05(2)	0	D
Common Stock								129,005	I	By The Robert and Sheryl Goldstein Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$34.28	11/05/2025		M			40,000	(3)	12/02/2031	Common Stock	40,000	$0	360,000	D
Option (Right to Buy)	$34.28	11/06/2025		M			360,000	(3)	12/02/2031	Common Stock	360,000	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.58 to $63.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.73 to $63.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These options vested in three equal annual installments beginning on December 3, 2022.

Remarks:

In addition to the options exercised and the underlying shares sold on November 5, 2025 and November 6, 2025, Mr. Goldstein holds options to purchase 2,500,000 shares that are vested and 403,800 restricted stock units that are unvested.

	/s/ Judy Tomkins, Attorney-in-Fact	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LVS (LVS) disclose on this Form 4?

Chairman & CEO Robert G. Goldstein exercised options at $34.28 and sold the resulting shares on 11/05/2025 and 11/06/2025.

How many LVS shares did Robert Goldstein sell and at what prices?

He sold 40,000 shares at a weighted average of $62.98 and 360,000 shares at a weighted average of $63.05.

Were these LVS sales tied to option exercises?

Yes. He exercised options at an exercise price of $34.28 before selling the underlying shares.

What are Robert Goldstein’s reported holdings after these transactions?

Direct balance for these entries was 0 shares, with 129,005 shares held indirectly by The Robert and Sheryl Goldstein Trust.

What awards remain outstanding for Robert Goldstein at LVS?

He reported 2,500,000 vested options remaining and 403,800 unvested RSUs.

What were the disclosed price ranges for the sales?

On 11/05/2025: $62.58–$63.06. On 11/06/2025: $62.73–$63.30.

When did the exercised options vest and when do they expire?

They vested in three equal annual installments beginning 12/03/2022 and had an expiration of 12/02/2031.